SecBot SecBot
Insider Cluster (3 insiders) ·Filed Feb 23, 2026

KALV

KalVista Pharmaceuticals, Inc.
BEARISH
Impact 6/10
Horizonweeks Processed8mo ago
Insider cluster: 3 insiders, $0.2M total
Actionable Insight ▼ Bearish

Monitor for upcoming 10-K or 8-K filings for potential disclosures on executive departures, slowed development timelines, or lack of partnership progress. Consider this insider selling as a cautionary signal, especially given the concentration among C-suite executives.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$15.56
T+0 close · Feb 22, 2026 · via day close
Latest settled
+71.98%
T+60 · $26.76
Vs SPY
+63.73%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Feb 23 $15.56entry
  2. T+1 · 9mo ago +1.35%α +0.61% · $15.77
  3. T+5 · 9mo ago +3.21%α +2.59% · $16.06
  4. T+20 · 8mo ago +6.68%α +10.63% · $16.60
  5. T+60 · 6mo ago +71.98%α +63.73% · $26.76
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Multiple C-suite executives at KalVista Pharmaceuticals (KALV) sold shares in a concentrated 7-day window, including the Chief Development Officer, CFO, and Chief Commercial Officer, realizing over $157,000 in total proceeds. The transactions include both cash sales and share movements (M) with no stated value, suggesting possible pre-arranged 10b5-1 plans or equity settlements. The cluster of insider selling by top executives raises caution despite lack of explicit negative filing disclosures.

Key Financial Metrics

Direction
selling
Total Value
$157.1K
Insiders
3

Key Facts

  • Chief Development Officer Christopher Yea sold 4,347 shares for $67,669.
  • CFO Brian Piekos sold 1,767 shares for $27,507.
  • Chief Commercial Officer Nicole Sweeny sold 3,975 shares for $61,878.
  • Total cash proceeds from insider sales: $157,054.
  • All cash sales occurred at $15.5668 per share on 2026-02-23.
  • Additional non-cash 'M' transactions (likely share releases or plan dispositions) totaling 18,125 shares across the three executives.

Financial Impact

$157,054 in insider selling over 7 days

insider ownershipinvestor sentimentpotential dilution signal

Risk Factors

  • Insider selling may indicate lack of confidence in near-term prospects.
  • Potential for negative newsflow ahead (e.g., trial delays, funding concerns) not yet public.
  • Non-cash 'M' transactions could signal broader equity disposition plans.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (8 trades, 7d window)cluster-KALV-1771980228290

US Market Status

Market Closed · Opens in 5h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 24, 2026